Open original FDA record ↗Recall record
- FDA identifier
- Z-1017-2019
- Company in FDA record
- Randox Laboratories Ltd.
- FDA record creation date
- Mar 15, 2019
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
The firm is conducting a Device Modification for Fructosamine Calibrator, Fructosamine Control 1 and Control 3 for the lots specified. The assigned value of Fructosamine in this calibrator and controls has now been re-assigned by a decrease of 25%.
Source facts
- Action
- The firm, Randox, notified the US distributor via email on 3 Dec 2018 with an "Urgent Medical Device Correction" letter dated 26 Nov 2018. The distributors and customers were instructed to remove the Value Sheet from existing stock and replace with the new Value Sheet and Important Notice. Customers were asked to take the following actions: " Please review all remaining stock and add the attached important notice to each kit. Replace the kit value sheet with the revised document provided. " Discuss the contents of this notice with your Medical Director. " Please retain this letter with your laboratory records and forward this letter to those who may have received this product. " Complete and return the response form to technical.services@randox.com within five working days. If you have any questions or concerns, please contact Randox Technical Services by email: maria.kelly@randox.com or +44 (0)28 9442 2413 or Tel: +1 304 728 2890 Toll Free 866 4 RANDOX or Email: Cheryl.O'Hagan@randox.com.
- Initiated
- 2018-12-03
- Root cause
- Under Investigation by firm
- Distribution
- US Distribution to states to: CA, ME. MI, and WV.
- Recall number
- Z-1017-2019
- Recall status
- Open, Classified
- CDRH record ID
- 169831
- FDA record created
- 2019-03-15
- Recall event number
- 81783